We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/pmt.12.18

SUMMARY Battlefield analgesia and post-injury pain management is a high priority within the military medical community. The combined military services of the USA have developed a Pain Task Force and clinical practice guidelines to ensure that adequate analgesia is provided to our wounded soldiers as far forward as the point of injury on the battlefield. As a result of this emphasis, novel analgesic techniques and equipment have led to improved pain management. Continuous peripheral nerve blocks, intranasal ketamine, battlefield acupuncture and other adjuncts have all been utilized safely and successfully. The ability to provide rapid analgesia as early in the course of injury as possible not only helps with the immediate pain of the soldier, but potentially minimizes the risk of developing chronic postinjury pain. During the long medical evacuation system the risks of both undertreatment and overtreatment of pain are very real. Future studies and observation will help to delineate best treatment regimens and pave the way for the next generation of medical providers to positively impact a soldier’s recovery. This article is written from the perspective of the USA with a focus on the conflicts in Afghanistan (Operation Enduring Freedom) and Iraq (Operation Iraqi Freedom).

Papers of special note have been highlighted as: ▪ of interest

References

  • Gawande A. Casualties of war–military care for the wounded from Iraq and Afghanistan. N. Engl. J. Med.351,2471–2475 (2004).
  • Montgomery SP, Swiecki CW, Shriver CD. The evaluation of casualties from Operation Iraqi Freedom on return to the continental United States from March to June 2003. J. Am. Coll. Surg.201,7–12 (2005).
  • Basbaum AI. Spinal mechanisms of acute and persistent pain. Reg. Anesth. Pain Med.24,59–67 (1999).
  • Lanser P, Gesell S. Pain management: the fifth vital sign. Health Benchmarks8(6),68–70, 62 (2001).
  • Hamilton GR, Baskett TF. In the arms of morpheus the development of morphine for postoperative pain relief. Can. J. Anaesth.47,367–374 (2000).
  • Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J. Pain3,159–180 (2002).
  • Allcock E, Spencer E, Frazer R et al. Continuous transverses abdominus plane (TAP) catheters in a combat surgical environment. Pain Med.11,1426–1429 (2010).
  • McDonnell JG, O’Donnell B, Curley B et al. The analgesic efficacy of transverse abdominus plane block after abdominal surgery: a prospective randomized controlled trial. Anesth. Analg.104(1),193–197 (2007).
  • Carney J, McDonnell JG, Ochana A et al. The transverse abdominus plane block provides effective postoperative analgesia in patients undergoing total abdominal hysterectomy. Anesth. Analg.107(6),2056–2060 (2008).
  • 10  Nations JA, Browning RF. Battlefield applications for handheld ultrasound. Ultrasound Quarterly27,171–176 (2011).
  • 11  Beck-Razi N, Fischer D, Michaelson M et al. The utility of focused assessment with sonography for trauma as a triage tool in multiple-casualty incidents during the second Lebanon war. J. Ultrasound Med.26,1149–1156 (2007).
  • 12  Scott DM. Regional anaesthesia and analgesia on the front line. Anaesth. Intensive Care37,1008–1011 (2009).
  • 13  Buckenmaier CC 3rd, Rupprecht C, McKnight G et al. Pain following battlefield injury and evacuation: a survey of 110 casualties from the wars in Iraq and Afghanistan. Pain Med.10,1487–1496 (2009).
  • 14  Buckenmaier CC 3rd, McKnight G, Winkley J et al. Continuous peripheral nerve block for battlefield anesthesia and evacuation. Reg. Anesth. Pain Med.30,202–205 (2005).
  • 15  Breslow JM, Monroy MA, Daly JM et al. Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection. J. Neuroimmune Pharmacol.6,551–565 (2011).
  • 16  Chelly JE, Greger J, Gebhard R et al. Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty. J. Arthroplasty16,436–445 (2001).▪ Highlights the benefits of regional anesthesia, as well as the safety of maintaining long-term infusions through catheters.
  • 17  Hadzic A, Williams BA, Karaca PE et al. For outpatient rotator cuff surgery, nerve block anesthesia provides superior same-day recovery over general anesthesia. Anesthesiology102,1001–1007 (2005).▪ Highlights the benefits of regional anesthesia, as well as the safety of maintaining long-term infusions through catheters.
  • 18  Borgeat A, Kalberer F, Jacob H et al. Patient-controlled interscalene analgesia with ropivacaine 0.2% versus bupivacaine 0.15% after major open shoulder surgery: the effects on hand motor function. Anesth. Analg.92,218–223 (2001).
  • 19  Cucchiaro G, Ganesh A. The effects of clonidine on postoperative analgesia after peripheral nerve block in children. Anesth. Analg.104,532–536 (2007).
  • 20  Bleckner LL, Bina S, Kwon KH et al. Serum ropivacaine concentrations and local anesthetic toxicity in trauma patients receiving long-term peripheral nerve block catheters. Anesth. Analg.110(2),630–634 (2010).▪ Highlights the benefits of regional anesthesia, as well as the safety of maintaining long-term infusions through catheters.
  • 21  Capdevila X, Bringuier S, Borgeat A et al. Infectious risk of continuous nerve blocks. Anesthesiology110,182–188 (2009).
  • 22  Lai TT, Jaeger L, Jones BL et al. Continuous peripheral nerve block catheter infections in combat-related injuries: a case report of five soldiers from operation enduring freedom/operation Iraqi freedom. Pain Med.12,1676–1781 (2011).
  • 23  Hillerup S, Bakke M, Larsen JO, Thomsen CE, Gerds TA. Concentration-dependent neurotoxicity of articaine: an electrophysiological and stereological study of the rat sciatic nerve. Anesth. Analg.112,1330–1338 (2011).
  • 24  Horlocker TT, Wedel DJ, Rowlingson JC et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg. Anesth. Pain Med.35(1),64–101 (2010).
  • 25  Liu SS, Buvanendran A, Viscusi ER et al. Uncomplicated removal of epidural catheters in 4365 patients with international normalized ratio greater than 1.4 during initiation of warfarin therapy. Reg. Anesth. Pain Med.36(3),231–235 (2011).
  • 26  Chelly JE, Szczodry DM, Neumann KJ et al. International normalized ratio and prothrombin time values before the removal of a lumbar plexus catheter in patients receiving warfarin after total hip replacement. Br. J. Anaesth.101,250–254 (2008).
  • 27  Aroni F, Iacovidou N, Dontas I et al. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug. J. Clin. Pharmacol.49,957–964 (2009).
  • 28  Bell RF, Dahl JB, Moore RA, Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst. Rev.25(1),CD004603 (2006).
  • 29  Chia YY, Liu K, Liu YC et al. Adding ketamine in a multimodal patient-controlled epidural regimen reduces postoperative pain and analgesic consumption. Anesth. Analg.86,1245–1249 (1998).
  • 30  Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth. Analg.99,482–495 (2004).
  • 31  Sinner B, Graf BM. Ketamine. Handb. Exp. Pharmacol.182,313– 333 (2008).
  • 32  LeRoy C, Laboureyras E, Gavello-Baudy S et al. Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization via a NMDA-dependent process. J. Pain12,1069–1079 (2011).
  • 33  Forero M, ChanPS, Restrepo-Garces CE. Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion. Pain Pract.12,154–158 (2012).
  • 34  Nanobashvili J, Kopadze T, Tvaladze M. War injuries of major extremity arteries. World J. Surg.27,134–139 (2003).
  • 35  Koo PJ. Postoperative pain management with a patient-controlled transdermal delivery system for fentanyl. Am. J. Health Syst. Pharm.62,1171–1176 (2005).▪ Highlights some of the emerging pharmacology and technology in the treatment of pain.
  • 36  Bell RF, Kalso E. Is intranasal ketamine an appropriate treatment for chronic non-cancer breakthrough pain? Pain108,1–2 (2004).
  • 37  Carr DB, Goudas LC, Denman WT et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain108,17–27 (2004).
  • 38  Moodie JE, Brown CR, Bisley EJ et al. The safety and analgesic efficacy of intranasal ketorolac in patients with postoperative pain. Anesth. Analg.107(6),2025–2031 (2008).
  • 39  Schutz RA, Fong L, Chang Y, Royal MA. Open-label, four-period, randomized crossover study to determine the comparative pharmacokinetics of oral and intravenous acetaminophen administration in healthy male volunteers. Presentated at: American Society of Regional Anesthesia and Pain 32nd Annual Meeting and Workshops. Vancouver, Canada, 19–22 April 2007 (Poster).
  • 40  Pettersson PH, Jakobsson J, Owall A. Intravenous acetaminophen reduced the use of opioids compared with oral administration after coronary artery bypass grafting. J. Cardiothor. Vasc. Anesth.19,306–309 (2005).
  • 41  Exparel®, prescribing information. Pacira Pharmaceuticals, NJ, USA (2011).
  • 42  Singla N. A Phase 2 multicenter, randomized, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of sublingual sufentanil NanoTab™ in patients following major abdominal surgery. Reg. Anesth. Pain Med.9 (2010) (Abstract only).
  • 43  Goertz CM, Niemtzow R, Burns SM, Fritts MJ, Crawford CC, Jonas WB. Auricular acupuncture in the treatment of acute pain syndromes: a pilot study. Mil. Med.171(10),1010–1014 (2006).▪ Highlights some of the emerging pharmacology and technology in the treatment of pain.
  • 44  Niemtzow R. Battlefield acupuncture. Med. Acupuncture1–11 (2007).
  • 45  Ketz AK. The experience of phantom limb pain in patients with combat-related traumatic amputations. Arch. Phys. Med. Rehabil.89,1127–1132 (2008).
  • 46  Ziegler-Graham K, MacKenzie EI, Ephraim PL et al. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch. Phys. Med. Rehabil.89,422–429 (2008).
  • 47  Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr. Opin Anaesthesiol.20,456–472 (2007).
  • 48  Chu LC, Tsaur ML, Lin CS et al. Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats. Br. J. Anaesth.106,699–705 (2011).
  • 49  Huxtable CA, Roberts LJ, Somogyi AA et al. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth. Intensive Care39,804–823 (2011).
  • 50  Merskey H, Bogduk N. Complex regional pain syndrome, type I. In: Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Merskey H, Bogduk N (Eds). IASP Press, WA, USA, 41–42 (1994).
  • 51  Demir SE, Ozaras N, Karamehmetoglu SS et al. Risk factors for complex regional pain syndrome in patients with traumatic extremity injury. Ulus Travma Acil Cerrahi Derg.16(2),144–148 (2010).